Received May 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | H3074 | — |
possible expired dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a male patient who received HBV (Engerix B) (batch number H3O74) and (batch number H3074) for prophylaxis. On 08-MAR-2025, the patient received Engerix B. On 08-MAR-2025, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: possible expired dose). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 09-MAY-2025 Reporter stated that a nurse have administered a vaccine (Engerix-B), and the expiration date that they discharged , if that was the correct expiration date, it will be expired at the time of the administration. The patient received expired vaccine, which led to expired vaccine used.